From: Minimizing Risk of Nephrogenic systemic fibrosis in Cardiovascular Magnetic Resonance
Patients with severely impaired renal function | high risk GBCAs are contraindicated |
medium and low risk GBCAs: use lowest possible dose, pause at least 7d between two GBCA enhanced procedures | |
Patients with moderately impaired renal function | High risk GBCAs: use single injection of minimum dose, pause of 7d between two GBCA enhanced procedures |
Medium and low risk GBCAs: use minimum dose, pause of 7d between two GBCA enhanced procedures | |
Toddlers < 1yo | High, medium and low risk GBCAs: use single injection of minimum dose, pause of 7d between two GBCA enhanced procedures |
Infants < 4wks | high risk GBCAs are contraindicated |
medium and low risk GBCAs: use lowest possible dose, pause at least 7d between two GBCA enhanced procedures | |
Breast feeding | High risk GBCAs: pause for 24 h |
Medium and low risk GBCAs: consider pause for 24 h | |
Perioperative phase of liver transplants | high risk GBCAs are contraindicated |
medium and low risk GBCAs: use lowest possible dose, pause at least 7d between two GBCA enhanced procedures |